Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration
Wednesday, June 28th, 2006 Biopharmaceutical company Genaera Corporation has commenced a multi-center phase II clinical trial to explore the efficacy and safety of higher doses of its investigational drug Evizon for the treatment of the eye disease, wet age-related macular degeneration.
The study is designed to evaluate up to 140 patients with wet age-related macular degeneration (AMD) treated with Evizon [...]
